Nicholas M Durham (Nick M Durham)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

Journal for immunotherapy of cancer

Johns Hopkins School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Johns Hopkins School of Medicine

United States

PHD :: Immunology

Publications

Lakshmi Nayak, Nathan Standifer, Jorg Dietrich, Jennifer L Clarke, Gavin P Dunn, Michael Lim, Timothy Cloughesy, Hui Kong Gan, Elizabeth Flagg, Elizabeth George, Sarah Gaffey, Julia Hayden, Christina Holcroft, Patrick Y Wen, Mary Macri, Andrew J Park, Toni Ricciardi, Aileen Ryan, Paul Schwarzenberger, Ralph Venhaus, Melissa de Los Reyes, Nicholas M Durham, Todd Creasy, Raymond Y Huang, Thomas Kaley, David A Reardon
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Charu Aggarwal, Nabil F Saba, Alain Patrick Algazi, Ammar Sukari, Tanguy Y Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo R Bonomi, Jean Boyer, Mark T Esser, Lily I Cheng, Sonia Agrawal, Emily C Jennings, Nicholas M Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gasco Hernandez, Rakesh Kumar
Safety and Efficacy of MEDI0457 Plus Durvalumab in Patients With Human Papillomavirus-associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Phillip A Swanson, Marcelino Padilla, Wesley Hoyland, Kelly McGlinchey, Paul A Fields, Sagida Bibi, Saul N Faust, Adrian B McDermott, Teresa Lambe, Andrew J Pollard, Nicholas M Durham, Elizabeth J Kelly, null null
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific TH1 response with a diverse TCR repertoire. Science translational medicine 13 (620) (2021)
Nicholas M Durham, Nick Holoweckyj, Randall S MacGill, Kelly McGlinchey, Ching Ching Leow, Scott H Robbins
GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory. Journal for immunotherapy of cancer 5 (2017)

Nicholas M Durham.css-eqlu8i{font-size:small;padding-left:4px;} (Nick M Durham)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas M Durham (Nick M Durham)